Healthcare

If you can't find what you want, Ask Us.

Refine Your Results

reset

Filter by Category

Location

Dates

FEATURED VENDORS

Showing 121-140 of 1215 results Sort by:

Courses

  • 121 Request Info

    Incident to Billing Services

    Overview: Incident-to coding for your non-physician practitioners (NPPs) services in conjunction with a supervising physician continues to generate confusion- and 2018 will be no exception. So, it's no surprise that these claims generate higher than average denials, and lead to hefty penalties for physician practices ranging from $163K to $1.5 million - but they don't have to.
  • 122 Request Info

    New Guidance on De-Identifying Protected Health Information under HIPAA

    Overview: This webinar will be addressing the ins and outs of identifying what is and what is not PHI, proper ways to disclose this information, common sense security methods, what we can and can't do under HIPAA relating to disclosures, and how to properly investigate a breach (or a suspected breach). We will also be addressing how practice/business managers (or compliance offers) need to get their HIPAA house in order before the imminent audits occur.
  • 123 Request Info

    Developing HIPAA Policies and Procedures

    Overview: Being in compliance with HIPAA involves not only ensuring you provide the appropriate patient rights and controls on your uses and disclosures of protected health information, but you also have the proper policies and procedures in place. A HIPAA Risk Management plan is your overall policies and procedures manual. If audited or the subject of a compliance review you will be required to show the government you have all the necessary policy and procedure documentation in place to address all the required safeguards.
  • 124 Request Info

    HIPAA Compliance for Attorneys and Law Firms

    Overview: This lesson will be addressing how law firms who work with protected health information need to get their HIPAA house in order as HIPAA is now fully enforced and the government is not using kid gloves any more. It will also address major changes under the Omnibus Rule and any other applicable updates for 2016 and beyond. There are an enormous amount of issues and risks for covered entities and business associates these days as it relates to patients' ability to sue and the Federal governments audit process. I will speak on specific experiences from over 17 years of experience in working as an outsourced compliance auditor, expert witness on HIPAA cases, and thoroughly explain how patients are now able to get cash remedies for wrongful disclosures of private health information. More importantly I will show you how to limit risks to your firm by simply taking proactive steps and utilizing best practices.
  • 125 Request Info

    2-Hour Virtual Seminar on Physician Employment Agreements, Contractor Agreements & Legally Compliant Compensation Models

    This webinar discusses the selection and employment contracting process that follows the identification of a suitable opportunity, You should attend this webinar to gain an understanding of what should and what should not be in a physician employment agreement, However, the agreement serves to protect against future disputes.
  • 126 Request Info

    HIPAA and Human Resources

    Overview: This lesson will be addressing what human resources managers need to know regarding health records of their employees. We will go through "do's and don'ts"and cover many frequently asked questions I have received through my 17-year career in HIPAA compliance. Human resources managers need to get their HIPAA house in order as this law is now fully enforced across the board and the government is not using kid gloves any more. It will also address major changes under the Omnibus Rule and any other applicable updates for 2019 and beyond.
  • 127 Request Info

    Drafting and Negotiating Physician Employment Contracts

    The webinar will focus on key regulatory requirements, key provisions, compensation and valuation considerations and potential pitfalls that should be avoided.
  • 128 Request Info

    Explores New SAMHSA Confidentiality Law for Substance Use Disorder Records(42 CFR Part 2)

    This webinar will guide healthcare professionals, health IT vendors, and insurance companies to maintain information security and patient confidentiality
  • 129 Request Info

    Curtailing Microbial Excursions and Investigations in Pharmaceutical Water Systems

    Overview: Water system microbial excursions are the bane of laboratories, utility operations, and production, often causing huge expenditures of labor for system sanitization and additional testing and quarantines of whole systems or specific outlets while fruitless investigations are mounted, not to mention the potential cost of product rejections when root causes are not definitive. Though some excursions are real and a sign of system control problems, most are probably self-inflicted, being caused by poorly designated "trigger values", poorly designed use points, or poorly executed sampling or testing. This presentation will explore these possible causes, including the symptoms of real (as well as false) water system problems, and provide effective alternatives to avoiding most of your current superfluous excursions, as well as how to build supporting data useful in pinpointing causes when investigations are indeed necessary.
  • 130 Request Info

    Carrier Food Safety Problems That May Occur during Transportation

    Overview: The FDA recommended course includes actual data, costs and examples from transportation tracked and measured operations, important definitions and reviews of federal and international requirements, established standards for management, HARPC, sanitation, temperature monitoring and traceability and training, types of adulterants, preventive practices, vehicle qualification, pre-shipment inspection, contamination flows, unseen bacteria, container temperature losses, obvious violations, the most advanced temperature monitoring, pallet types, carrier responsibilities, sanitation testing, and includes specific recommendations for carriers as well as shippers and receivers who receive carrier services.
  • 131 Request Info

    Preparing for OSHA Voluntary Protection Program (VPP)

    Overview: The OSHA Voluntary Protection Program (VPP) is the highest award in Health and Safety Excellence that OSHA presents to an organization. This training program will guide attendees with best practices in implementing the OSHA VPP program. There are five cornerstones or elements for VPP: Management commitment; Employee involvement; Workplace Analysis; Hazard Prevention and Control; and Training. Define the key elements and sub elements of the OSHA VPP program Learn how to get a baseline of the safety culture within your facility
  • 132 Request Info

    Medical Device Software Validation Meeting FDA Regulations

    Overview: This course will teach how to conduct a software validation program for medical devices containing software that will satisfy FDA requirements and produce a safe product. We will explain the role of risk analysis in validation. How software requirements are used in validation will be described. Why should you Attend: Testing software to prove that it works and has no bugs is not sufficient to obtain FDA approval. There are additional analyses and tests that FDA feels are necessary to prevent user injuries. These requirements were developed after analysis by the FDA of many recalled medical devices. In this webinar you will learn the testing that is required in addition to functional tests to produce a validated software product.
  • 133 Request Info

    Responsibilities of the Carrier Under the Final FDA FSMA Rules

    Overview: This is part 1 of a three part required training resulting from the finalization of new US FDA food transportation laws. Session 1, "Responsibilities of the Carrier Under the Final Rules" covers the Final Rules on the Sanitary Transportation of Human and Animal Foods (now law) as published by the Food and Drug Administration under the Food Safety Modernization Act (FSMA). This session covers the final rules. All carrier transportation operations personnel are required to take this and the subsequent two training sessions.
  • 134 Request Info

    Tools for Human Error Reduction

    Overview: Human error is known to be the major cause of quality and production losses in many industries. Although it is unlikely that human error will ever be totally eliminated, many human performance problems can be prevented. Human errors start at the design stage. From procedures, training, and workplace environment many variables that affect human behavior CAN be manipulated reducing the likelihood of these occurrences.
  • 135 Request Info

    Common False Beliefs for Microbial Control and Monitoring

    Overview: It is an unfortunate fact that most water systems today have been designed and are operated and controlled using at least some traditional concepts and methods that are downright wrong. So how could such traditions become so ingrained and be so wrong? How could well-intentioned benchmarking be so misguided? There are many reasons, which will be discussed, but regardless of the causes, we need to be aware of these myths and understand how it really should be done.
  • 136 Request Info

    21 CFR Part 11 Guidance for Electronic Records and Electronic Signatures

    Overview: The Webinar will focus on the importance of ensuring that electronic record/electronic signature (ER/ES) capability built into FDA-regulated computer systems meets compliance with 21 CFR Part 11. This includes development of a company philosophy and approach, and incorporating it into the overall computer system validation program and plans for individual systems that have this capability.
  • 137 Request Info

    Statistical Justification for Sample Size and the Use of Only 3 Lots

    Why should you Attend: Almost all manufacturing and development companies perform at least some process validation studies, but it is difficult to decide how many Lots to include in the study and how large the Sample per Lot should be. This webinar provides a "statistical" justification and method for determining Sample Sizes, and a statistical justification for using only 3 Lots (which is the typical number, especially in industries regulated by the FDA).
  • 138 Request Info

    FDA Inspections: From SOP to 483 in (2019)

    Overview: Does the FDA call in advance or just show up at my door? Where do I let the inspector go? Do I give them a tour? What should I let them see? Who should I let them talk to? Are they ever going to leave? Why should you Attend: This session will discuss how to prepare for the inspection, what to do during the inspection and the close-out interview, and how to respond to the inspection.
  • 139 Request Info

    Investigation and Root Cause Analysis to Meet FDA Expectations

    Overview: This live interactive presentation will also discuss the regulations associated with the detection, correction and prevention of human errors in GMP manufacturing and laboratory processes. Why should you Attend: We are often quick to ascribe fault to people rather than our systems, facilities, and operations. However, in this class, we will learn how to tell if you are too quick to ascribe guilt to people rather than probe deeper. We will focus on improved techniques to get to the real cause of the problem. With this information you will be able to develop meaningful CAPAs that have a chance to remedy these problems, the first time.
  • 140 Request Info

    Canadian Drug and Health Products Regulatory Landscape

    Overview: The focus will be on drugs, biologics and medical devices, We will also be providing an overview of how the regulatory landscape is currently evolving for most efficient strategic planning. Why should you Attend: This webinar will give you a snap shot of what is current, what is coming and what this means to anyone who is currently developing Drugs and other Health Products for the Canadian market. The focus will be on drugs, biologics and medical devices.